Biotechs continue to decline like tech stocks but the sector is adequately capitalized, analysts say.

Jim Cramer says many companies aren't prepared for extended shutdowns and they may not be able to get the credit they need to survive.

In a special edition of Mad money, Jim Cramer examines this brutal decline and lays out the game plan for next week -- live from Minneapolis ahead of the Super Bowl.

Jim Cramer highlights Shopify, Kinder Morgan, Thermo Fisher Scientific, Radius Health, Merck, Pfizer and more.

Jim Cramer focuses on Roku, Sierra Wireless, Visa, Cimarex Energy, First Solar, Halozyme Therapeutics.

"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.

"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.